S&P Futures
3,902.00 +4.25 (+0.11%) Dow Futures
31,241.00 +39.00 (+0.12%) Nasdaq Futures
11,838.00 -40.25 (-0.34%) Russell 2000 Futures
1,771.50 -3.40 (-0.19%) Crude Oil
110.35 +0.46 (+0.42%) Gold
1,845.10 +3.90 (+0.21%)
CONMED Corporation (CNMD)
Chart Events
Performance Outlook
| Previous Close | 111.71 |
| Open | 112.99 |
| Bid | 44.14 x 800 |
| Ask | 176.52 x 1200 |
| Day's Range | 110.01 - 113.26 |
| 52 Week Range | 107.08 - 159.11 |
| Volume | |
| Avg. Volume | 275,022 |
| Market Cap | 3.289B |
| Beta (5Y Monthly) | 1.53 |
| PE Ratio (TTM) | 58.11 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.80 (0.69%) |
| Ex-Dividend Date | Mar 14, 2022 |
| 1y Target Est | N/A |
- Business Wire
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla., May 24, 2022--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2022 to all shareholders of record as of June 15, 2022.
- Business Wire
CONMED Corporation Announces First Quarter 2022 Financial Results
LARGO, Fla., May 04, 2022--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2022.
- Business Wire
CONMED Announces Definitive Agreement to Acquire In2Bones Global, Inc.
LARGO, Fla., May 04, 2022--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period. The transaction is not subject to a financing condition. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval,
